<i>MAX</i> Mutations Cause Hereditary and Sporadic Pheochromocytoma and Paraganglioma
Nelly Burnichon(Inserm), Elisa Taschin(Istituto Oncologico Veneto), Miguel Quesada‐Charneco(Centre National de la Recherche Scientifique), Emiliano Honrado(Spanish National Cancer Research Centre), Nicole Paes Morales(The University of Texas at San Antonio Health Science Center), Jacques W.M. Lenders(Radboud University Nijmegen), F. Schillo(Centre National de la Recherche Scientifique), Jérôme Bertherat(Centre National de la Recherche Scientifique), Carlos Suárez(Hospital Universitario Central de Asturias), Giovanna Roncador(Spanish National Cancer Research Centre), Frederik J. Hes(Leiden University Medical Center), Aguirre A. de Cubas(Medical University of South Carolina), Macarena Ruiz‐Ferrer(Centre National de la Recherche Scientifique), Philippe Chanson(Bicêtre Hospital), Tamara Prodanov(Eunice Kennedy Shriver National Institute of Child Health and Human Development), Arjen R. Mensenkamp(Radboud University Nijmegen), Esther Korpershoek(Radboud University Nijmegen), Tonino Ercolino(Azienda Ospedaliero-Universitaria Careggi), Nan Qin(China Pharmaceutical University), Nasséra Abermil(Centre National de la Recherche Scientifique), Marinus J. Blok(Maastricht University), Luigi Mori(University of Brescia), Francesca Schiavi(Istituto Oncologico Veneto), Salud Borrego(Centre for Biomedical Network Research on Rare Diseases), Nicole Reisch(LMU Klinikum), Maurizio Castellano(Brescia University), Mara Giacchè, Sara Bobisse(Ludwig Cancer Research), Ronald R. de Krijger(University Medical Center Utrecht), Anna Merlo(Centre National de la Recherche Scientifique), Marta Barontini(Consejo Nacional de Investigaciones Científicas y Técnicas), Xavier Girerd(Sorbonne Université), Álvaro Gómez-Graña(Spanish National Cancer Research Centre), Yves‐Jean Bignon(Centre Jean Perrin), Alexander P.A. Stegmann(Radboud University Nijmegen), Laurence Amar(Unit of Functional and Adaptive Biology), Lucía Inglada‐Pérez(Spanish National Cancer Research Centre), Sandra Bernaldo de Quirós Fernández(Centre National de la Recherche Scientifique), Eleonora P.M. Corssmit(Leiden University Medical Center), Alberto Cascón(Spanish National Cancer Research Centre), Elena Rapizzi(El.En. Group (Italy)), Victoria M. Raymond(Guardant (United States)), Iñaki Comino‐Méndez(Breast Cancer Now), Pierre‐François Plouin(Hôpital Broussais), María‐Dolores Chiara(Universidad de Oviedo), Arnaud Murat(Centre National de la Recherche Scientifique), P. Pierre(Centre National de la Recherche Scientifique), E. Gómez(Maastricht University Medical Centre), Isabelle Guilhem(Centre National de la Recherche Scientifique), Rocío Letón
Cited by 330
Related Papers
Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort
|The Lancet Diabetes & Endocrinology|2017|951
The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma
|Cell Reports|2018|818
Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma
|Cancer Cell|2017|791
SDH Mutations Establish a Hypermethylator Phenotype in Paraganglioma
|Cancer Cell|2013|772
Guidelines for Acromegaly Management: An Update
|The Journal of Clinical Endocrinology & Metabolism|2009|763